PATENT CLAIM ANALYSIS

Application Number: 15892314
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "04400A"]

Abstract:
The present invention provides novel, stable lipid particles having a non-lamellar structure and comprising one or more active agents or therapeutic agents, methods of making such lipid particles, and methods of delivering and/or administering such lipid particles. More particularly, the present invention provides stable nucleic acid-lipid particles (SNALP) that have a non-lamellar structure and that comprise a nucleic acid (such as one or more interfering RNA), methods of making the SNALP, and methods of delivering and/or administering the SNALP.

Claim (Index 8):
The composition of  claim 5 , wherein from about 20% to about 40% of the nucleotides in the double-stranded region comprise modified nucleotides.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 88.0
- Lexical Diversity: 2.06818
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13807288', '15153487', '14642452', '12828202', '12343342']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8453962131412044
- 35 USC 102 Novelty (BERT): 0.5924409117246907
- Combined Prediction Score: 0.8201006829995531
- Mean Citation Score: 563.2259019999998
- Max Citation Score: 643.6443
- Similarity Product: 390.8258233690739

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test